Pharma News

On November 12, Reuters reported that US pharmaceutical giant Pfizer plans to sell its hospital drugs unit and is currently working with Goldman Sachs to evaluate it.

In an effort to protect the patent rights for radiation ligand therapy, Novartis has filed a lawsuit against Eli Lilly and its partner Lantheus, alleging infringement of the patent rights for the prostate cancer drug Pluvicto.

Shilpa Medicare, a leading integrated pharmaceutical group, today announced its CDMO partner, Unicycive Therapeutics, Inc. Has successfully had the U.S. Food and Drug Administration (USFDA) accept a New Drug Application (NDA) for lanthanum oxycarbonate (O

According to the latest market research data, the Indian pharmaceutical market achieved a sales growth of 6.1% in October despite a decline in overall sales. This growth figure was confirmed by Pharmarack, a heart and skin treatment company. "Most therapi

The U.S. Food and Drug Administration (FDA) made an important decision on Tuesday, denying full approval of Intercept Pharmaceuticals' liver disease drug. The decision raises questions about the drug's future market prospects. Still, Intercept Pharmaceuti

Flare Therapeutics has announced a major strategic discovery collaboration agreement with Roche, a leading global pharmaceutical company. The main goal of this collaboration is to jointly develop small molecule cancer therapies that target transcription f

On November 6, 2024, A-share listed company Hengrui Pharmaceutical announced that the second lock-up period of the company's employee stock ownership plan implemented in 2022 will expire on November 7, 2024.

In the recent period of time, according to the report of FIERCE Pharma, following Takeda, Pfizer, UCB, Wuxi Apptec and other well-known pharmaceutical companies have announced their withdrawal, another multinational pharmaceutical giant - GlaxoSmithKline

With the conclusion of the November 5 election and the successful election of Mr. Donald Trump as President, the pharmaceutical industry is bracing itself for four years of uncertainty.

Chinese scientists have proposed a regionally specific dietary pattern that they stress is essential to improve the eating habits of the country's population and an effective way to preserve natural and environmental resources amid the rising prevalence o

BioMADE, a Biomanufacturing innovation institute initiated and founded by the U.S. Department of Defense, recently announced 17 selected projects with the goal of further promoting the scale development and commercialization of biomanufacturing products i

Bangalore-based pharmaceutical giant Abbott India on Thursday released its second quarter financial results, showing significant profit growth. This increase was mainly driven by strong demand for its gastrointestinal and anti-infective drugs.

Following the successful election of Donald Trump as the 47th President of the United States, India's life sciences and pharmaceutical industries are watching closely to see how the new administration's "America First" policies will affect US trade dynami

AstraZeneca announced on Wednesday that its China chief, Leon Wang, had been detained by Chinese authorities. Although the specific reason for the detention is unclear, the company said it does not believe the incident is related to a major health insuran

Danish biotech company Zealand Pharma announced in a statement on Thursday that they expect to initiate a phase 2b clinical trial of petrelintide, its candidate for the treatment of obesity, in the fourth quarter of 2024.

On November 6, 2024, Novo Nordisk announced its financial results for the third quarter of 2024.

According to the results of the National Enterprise Credit Information Disclosure System, Astrazeneca's legal representative, responsible person, chief representative and executive of partnership affairs have been changed.

At Viking's ObesityWeek conference on Sunday, data from a study got a lot of attention. The early study, which included 92 participants, showed that those who took a 100 mg dose of Viking tablets lost an average of 6.8 percent of their body weight in just

On October 28, 2024, AbbVie, the world's leading pharmaceutical company, announced a major transaction to acquire all outstanding shares of Aliada for $1.4 billion in cash.

In order to maintain its leading position in the weight loss drug market, Novo Nordisk is currently actively developing a new GLP-1 drug called CagriSema, according to the latest media reports.